Is STERIS Plc Stock a Good Investment?

STERIS Plc Investment Advice

  STE
To provide specific investment advice or recommendations on STERIS plc stock, we recommend investors consider the following general factors when evaluating STERIS plc. This will help you to make an informed decision on whether to include STERIS Plc in one of your diversified portfolios:
  • Examine STERIS Plc's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
  • Research STERIS Plc's leadership team and their track record. Good management can help STERIS Plc navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
  • Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact STERIS Plc's business and its evolving consumer preferences.
  • Compare STERIS Plc's performance and market position to its competitors. Analyze how STERIS Plc is positioned in terms of product offerings, innovation, and market share.
  • Check if STERIS Plc pays a dividend and its dividend yield and payout ratio.
  • Review what financial analysts are saying about STERIS Plc's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in STERIS plc stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if STERIS plc is a good investment.
 
Sell
 
Buy
Strong Buy
Macroaxis provides recommendation on STERIS plc to complement and cross-verify current analyst consensus on STERIS plc. Our trade recommendation engine determines the firm's potential to grow exclusively from the perspective of an investor's current risk tolerance and investing horizon. To make sure STERIS plc is not overpriced, please validate all STERIS Plc fundamentals, including its number of shares shorted, total debt, beta, as well as the relationship between the gross profit and short ratio . Given that STERIS plc has a price to earning of 36.93 X, we advise you to double-check STERIS plc market performance and probability of bankruptcy to ensure the company can sustain itself next year given your current risk tolerance and investing horizon.

Market Performance

OKDetails

Volatility

Very steadyDetails

Hype Condition

StaleDetails

Current Valuation

UndervaluedDetails

Odds Of Distress

LowDetails

Economic Sensitivity

Slowly supersedes the marketDetails

Investor Sentiment

AlarmedDetails

Analyst Consensus

BuyDetails

Financial Leverage

Not RatedDetails

Reporting Quality (M-Score)

UnavailableDetails

Examine STERIS Plc Stock

Researching STERIS Plc's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 96.0% of the company shares are owned by institutional investors. The book value of STERIS Plc was at this time reported as 65.31. The company recorded earning per share (EPS) of 6.21. STERIS plc last dividend was issued on the 20th of February 2025. The entity had 2:1 split on the 25th of August 1998.
To determine if STERIS Plc is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding STERIS Plc's research are outlined below:
Over 96.0% of the company shares are owned by institutional investors
Latest headline from finance.yahoo.com: STERIS Gets a Buy Call from Jim Cramer Just a Strong Company
STERIS Plc uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in STERIS plc. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to STERIS Plc's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
7th of February 2024
Upcoming Quarterly Report
View
8th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
8th of May 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of March 2023
Last Financial Announcement
View
Earnings surprises can significantly impact STERIS Plc's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises STERIS Plc's investors have experienced.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2000-07-26
2000-06-30-0.010.010.02200 
1996-10-30
1996-09-300.150.170.0213 
2006-11-07
2006-09-300.220.250.0313 
2005-11-09
2005-09-300.210.240.0314 
2002-04-25
2002-03-310.230.260.0313 
2001-07-19
2001-06-300.050.080.0360 
1997-04-30
1997-03-310.20.230.0315 
2002-07-23
2002-06-300.140.180.0428 

STERIS Plc Target Price Consensus

STERIS target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. STERIS Plc's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
   9  Buy
Most STERIS analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand STERIS stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of STERIS plc, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

STERIS Plc Target Price Projection

STERIS Plc's current and average target prices are 225.47 and 248.26, respectively. The current price of STERIS Plc is the price at which STERIS plc is currently trading. On the other hand, STERIS Plc's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

STERIS Plc Market Quote on 20th of March 2025

Low Price223.4Odds
High Price226.5Odds

225.47

Target Price

Analyst Consensus On STERIS Plc Target Price

Low Estimate225.92Odds
High Estimate275.57Odds

248.2625

Historical Lowest Forecast  225.92 Target Price  248.26 Highest Forecast  275.57
Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on STERIS plc and the information provided on this page.

STERIS Plc Analyst Ratings

STERIS Plc's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about STERIS Plc stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of STERIS Plc's financials, market performance, and future outlook by experienced professionals. STERIS Plc's historical ratings below, therefore, can serve as a valuable tool for investors.

Know STERIS Plc's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as STERIS Plc is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading STERIS plc backward and forwards among themselves. STERIS Plc's institutional investor refers to the entity that pools money to purchase STERIS Plc's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Sustainable Growth Advisers, Lp2024-12-31
1.4 M
Mitsubishi Ufj Asset Management Co.,ltd2024-12-31
1.3 M
Franklin Resources Inc2024-12-31
1.2 M
Northern Trust Corp2024-12-31
1.2 M
Norges Bank2024-12-31
1.2 M
Bessemer Group Inc2024-12-31
1.1 M
Pictet Asset Manangement Sa2024-12-31
1.1 M
Principal Financial Group Inc2024-12-31
1.1 M
Impax Asset Management Group Plc2024-09-30
1.1 M
Vanguard Group Inc2024-12-31
11.9 M
Blackrock Inc2024-12-31
9.1 M
Note, although STERIS Plc's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

STERIS Plc's market capitalization trends

The company currently falls under 'Large-Cap' category with a total capitalization of 22.13 B.

Market Cap

5.61 Billion

STERIS Plc's profitablity analysis

Last ReportedProjected for Next Year
Return On Tangible Assets 0.07  0.08 
Return On Capital Employed 0.09  0.14 
Return On Assets 0.04  0.07 
Return On Equity 0.07  0.11 
The company has Net Profit Margin of 0.09 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.18 %, which entails that for every 100 dollars of revenue, it generated $0.18 of operating income.
Determining STERIS Plc's profitability involves analyzing its financial statements and using various financial metrics to determine if STERIS Plc is a good buy. For example, gross profit margin measures STERIS Plc's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of STERIS Plc's profitability and make more informed investment decisions.

STERIS Plc's Earnings Breakdown by Geography

Please note, the presentation of STERIS Plc's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, STERIS Plc's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of STERIS Plc's management manipulating its earnings.

Evaluate STERIS Plc's management efficiency

STERIS plc has Return on Asset of 0.0559 % which means that on every $100 spent on assets, it made $0.0559 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0961 %, implying that it generated $0.0961 on every 100 dollars invested. STERIS Plc's management efficiency ratios could be used to measure how well STERIS Plc manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to 0.08. The current year's Return On Capital Employed is expected to grow to 0.14. At present, STERIS Plc's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 1.2 B, whereas Intangibles To Total Assets are forecasted to decline to 0.26.
Last ReportedProjected for Next Year
Book Value Per Share 57.54  60.41 
Tangible Book Value Per Share 1.46  2.87 
Enterprise Value Over EBITDA 20.36  17.29 
Price Book Value Ratio 3.98  4.48 
Enterprise Value Multiple 20.36  17.29 
Price Fair Value 3.98  4.48 
Enterprise Value6.4 B6.7 B
Understanding the operational decisions made by STERIS Plc management offers insights into its financial robustness. This evaluation is crucial for assessing the stock's investment potential.
Dividend Yield
0.01
Forward Dividend Yield
0.01
Forward Dividend Rate
2.28
Beta
0.92

Basic technical analysis of STERIS Stock

As of the 20th of March, STERIS Plc has the coefficient of variation of 1017.62, and Risk Adjusted Performance of 0.0897. In connection with fundamental indicators, the technical analysis model makes it possible for you to check practical technical drivers of STERIS plc, as well as the relationship between them. Please validate STERIS plc information ratio, as well as the relationship between the potential upside and kurtosis to decide if STERIS Plc is priced adequately, providing market reflects its prevalent price of 225.47 per share. Given that STERIS plc has jensen alpha of 0.1309, we advise you to double-check STERIS plc's current market performance to make sure the company can sustain itself at some point in the future.

STERIS Plc's insider trading activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific STERIS Plc insiders, such as employees or executives, is commonly permitted as long as it does not rely on STERIS Plc's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases STERIS Plc insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

STERIS Plc's Outstanding Corporate Bonds

STERIS Plc issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. STERIS plc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most STERIS bonds can be classified according to their maturity, which is the date when STERIS plc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Understand STERIS Plc's technical and predictive indicators

Using predictive indicators to make investment decisions involves analyzing STERIS Plc's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.

Consider STERIS Plc's intraday indicators

STERIS Plc intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of STERIS Plc stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

STERIS Plc Corporate Filings

8K
3rd of March 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
10Q
7th of February 2025
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
ViewVerify
F4
27th of November 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
25th of November 2024
Other Reports
ViewVerify
STERIS Plc time-series forecasting models is one of many STERIS Plc's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary STERIS Plc's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

STERIS Stock media impact

Far too much social signal, news, headlines, and media speculation about STERIS Plc that are available to investors today. That information is available publicly through STERIS media outlets and privately through word of mouth or via STERIS internal channels. However, regardless of the origin, that massive amount of STERIS data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of STERIS Plc news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of STERIS Plc relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to STERIS Plc's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive STERIS Plc alpha.

STERIS Plc Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards STERIS Plc can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

STERIS plc Historical Investor Sentiment

Investor biases related to STERIS Plc's public news can be used to forecast risks associated with an investment in STERIS. The trend in average sentiment can be used to explain how an investor holding STERIS can time the market purely based on public headlines and social activities around STERIS plc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
STERIS Plc's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for STERIS Plc and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average STERIS Plc news discussions. The higher the estimate score, the more favorable the investor's outlook on STERIS Plc.

STERIS Plc Maximum Pain Price Across June 20th 2025 Option Contracts

STERIS Plc's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of STERIS Plc close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of STERIS Plc's options.

STERIS Plc Corporate Directors

Richard BreedenIndependent DirectorProfile
Michael WoodIndependent DirectorProfile
Paul MartinIndependent DirectorProfile
Jacqueline KosecoffIndependent DirectorProfile
When determining whether STERIS plc is a strong investment it is important to analyze STERIS Plc's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact STERIS Plc's future performance. For an informed investment choice regarding STERIS Stock, refer to the following important reports:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in STERIS plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For information on how to trade STERIS Stock refer to our How to Trade STERIS Stock guide.
You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of STERIS Plc. If investors know STERIS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about STERIS Plc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.238
Dividend Share
2.18
Earnings Share
6.21
Revenue Per Share
54.684
Quarterly Revenue Growth
0.056
The market value of STERIS plc is measured differently than its book value, which is the value of STERIS that is recorded on the company's balance sheet. Investors also form their own opinion of STERIS Plc's value that differs from its market value or its book value, called intrinsic value, which is STERIS Plc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because STERIS Plc's market value can be influenced by many factors that don't directly affect STERIS Plc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between STERIS Plc's value and its price, as these two are different measures arrived at by various means. Investors typically determine if STERIS Plc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, STERIS Plc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.